CDTX logo

Cidara Therapeutics, Inc. (CDTX) Cash from investing

annual CFI:

-$129.00K+$376.00K(+74.46%)
December 31, 2024

Summary

  • As of today (September 18, 2025), CDTX annual cash flow from investing activities is -$129.00 thousand, with the most recent change of +$376.00 thousand (+74.46%) on December 31, 2024.
  • During the last 3 years, CDTX annual CFI has fallen by -$88.00 thousand (-214.63%).
  • CDTX annual CFI is now -100.51% below its all-time high of $25.48 million, reached on December 31, 2016.

Performance

CDTX Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCDTXcash flow metrics

quarterly CFI:

$0.00-$185.00K(-100.00%)
June 30, 2025

Summary

  • As of today (September 18, 2025), CDTX quarterly cash flow from investing activities is $0.00, with the most recent change of -$185.00 thousand (-100.00%) on June 30, 2025.
  • Over the past year, CDTX quarterly CFI has stayed the same.
  • CDTX quarterly CFI is now -100.00% below its all-time high of $35.39 million, reached on December 31, 2016.

Performance

CDTX quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCDTXcash flow metrics

TTM CFI:

$79.00K$0.00(0.00%)
June 30, 2025

Summary

  • As of today (September 18, 2025), CDTX TTM cash flow from investing activities is $79.00 thousand, unchanged on June 30, 2025.
  • Over the past year, CDTX TTM CFI has increased by +$406.00 thousand (+124.16%).
  • CDTX TTM CFI is now -99.86% below its all-time high of $57.61 million, reached on June 30, 2017.

Performance

CDTX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCDTXcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

CDTX Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+74.5%0.0%+124.2%
3 y3 years-214.6%+100.0%+170.5%
5 y5 years-268.6%+100.0%+159.8%

CDTX Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-214.6%+74.5%-100.0%+100.0%at high+115.6%
5 y5-year-268.6%+74.5%-100.0%+100.0%at high+115.6%
alltimeall time-100.5%+99.7%-100.0%+100.0%-99.9%+100.1%

CDTX Cash from investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$0.00(-100.0%)
$79.00K(0.0%)
Mar 2025
-
$185.00K(>+9900.0%)
$79.00K(-161.2%)
Dec 2024
-$129.00K(-74.5%)
$0.00(-100.0%)
-$129.00K(-58.0%)
Sep 2024
-
-$106.00K(<-9900.0%)
-$307.00K(-6.1%)
Jun 2024
-
$0.00(-100.0%)
-$327.00K(-24.7%)
Mar 2024
-
-$23.00K(-87.1%)
-$434.00K(-14.1%)
Dec 2023
-$505.00K(+328.0%)
-$178.00K(+41.3%)
-$505.00K(+50.3%)
Sep 2023
-
-$126.00K(+17.8%)
-$336.00K(+53.4%)
Jun 2023
-
-$107.00K(+13.8%)
-$219.00K(+71.1%)
Mar 2023
-
-$94.00K(+944.4%)
-$128.00K(+8.5%)
Dec 2022
-$118.00K(+187.8%)
-$9000.00(0.0%)
-$118.00K(+8.3%)
Sep 2022
-
-$9000.00(-43.8%)
-$109.00K(-2.7%)
Jun 2022
-
-$16.00K(-81.0%)
-$112.00K(-0.9%)
Mar 2022
-
-$84.00K(<-9900.0%)
-$113.00K(+175.6%)
Dec 2021
-$41.00K(-78.0%)
$0.00(-100.0%)
-$41.00K(0.0%)
Sep 2021
-
-$12.00K(-29.4%)
-$41.00K(-50.6%)
Jun 2021
-
-$17.00K(+41.7%)
-$83.00K(-48.8%)
Mar 2021
-
-$12.00K(<-9900.0%)
-$162.00K(-12.9%)
Dec 2020
-$186.00K(+431.4%)
$0.00(-100.0%)
-$186.00K(0.0%)
Sep 2020
-
-$54.00K(-43.8%)
-$186.00K(+40.9%)
Jun 2020
-
-$96.00K(+166.7%)
-$132.00K(+112.9%)
Mar 2020
-
-$36.00K(<-9900.0%)
-$62.00K(+77.1%)
Dec 2019
-$35.00K
$0.00(0.0%)
-$35.00K(-100.8%)
DateAnnualQuarterlyTTM
Sep 2019
-
$0.00(-100.0%)
$4.42M(-68.6%)
Jun 2019
-
-$26.00K(+188.9%)
$14.11M(+2.0%)
Mar 2019
-
-$9000.00(-100.2%)
$13.84M(-3.2%)
Dec 2018
$14.30M(+219.9%)
$4.46M(-54.0%)
$14.30M(+182.7%)
Sep 2018
-
$9.69M(-3351.0%)
$5.06M(-134.9%)
Jun 2018
-
-$298.00K(-166.1%)
-$14.50M(+127.9%)
Mar 2018
-
$451.00K(-109.4%)
-$6.36M(-242.3%)
Dec 2017
$4.47M(-82.5%)
-$4.78M(-51.5%)
$4.47M(-90.0%)
Sep 2017
-
-$9.87M(-225.9%)
$44.64M(-22.5%)
Jun 2017
-
$7.84M(-30.5%)
$57.61M(+56.6%)
Mar 2017
-
$11.28M(-68.1%)
$36.78M(+44.3%)
Dec 2016
$25.48M(-155.3%)
$35.39M(+1043.3%)
$25.48M(-576.7%)
Sep 2016
-
$3.10M(-123.8%)
-$5.35M(-90.9%)
Jun 2016
-
-$12.99M(>+9900.0%)
-$58.93M(+27.9%)
Mar 2016
-
-$13.00K(-100.3%)
-$46.07M(-0.0%)
Dec 2015
-$46.09M(+4550.7%)
$4.56M(-109.0%)
-$46.09M(-9.3%)
Sep 2015
-
-$50.49M(>+9900.0%)
-$50.79M(>+9900.0%)
Jun 2015
-
-$126.00K(+306.5%)
-$470.00K(-54.0%)
Mar 2015
-
-$31.00K(-78.8%)
-$1.02M(+3.0%)
Dec 2014
-$991.00K(<-9900.0%)
-$146.00K(-12.6%)
-$991.00K(+17.3%)
Sep 2014
-
-$167.00K(-75.3%)
-$845.00K(+24.6%)
Jun 2014
-
-$677.00K(>+9900.0%)
-$678.00K(>+9900.0%)
Mar 2014
-
-$1000.00
-$1000.00
Dec 2013
$0.00
-
-

FAQ

  • What is Cidara Therapeutics, Inc. annual cash flow from investing activities?
  • What is the all time high annual CFI for Cidara Therapeutics, Inc.?
  • What is Cidara Therapeutics, Inc. annual CFI year-on-year change?
  • What is Cidara Therapeutics, Inc. quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Cidara Therapeutics, Inc.?
  • What is Cidara Therapeutics, Inc. quarterly CFI year-on-year change?
  • What is Cidara Therapeutics, Inc. TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Cidara Therapeutics, Inc.?
  • What is Cidara Therapeutics, Inc. TTM CFI year-on-year change?

What is Cidara Therapeutics, Inc. annual cash flow from investing activities?

The current annual CFI of CDTX is -$129.00K

What is the all time high annual CFI for Cidara Therapeutics, Inc.?

Cidara Therapeutics, Inc. all-time high annual cash flow from investing activities is $25.48M

What is Cidara Therapeutics, Inc. annual CFI year-on-year change?

Over the past year, CDTX annual cash flow from investing activities has changed by +$376.00K (+74.46%)

What is Cidara Therapeutics, Inc. quarterly cash flow from investing activities?

The current quarterly CFI of CDTX is $0.00

What is the all time high quarterly CFI for Cidara Therapeutics, Inc.?

Cidara Therapeutics, Inc. all-time high quarterly cash flow from investing activities is $35.39M

What is Cidara Therapeutics, Inc. quarterly CFI year-on-year change?

Over the past year, CDTX quarterly cash flow from investing activities has changed by $0.00 (0.00%)

What is Cidara Therapeutics, Inc. TTM cash flow from investing activities?

The current TTM CFI of CDTX is $79.00K

What is the all time high TTM CFI for Cidara Therapeutics, Inc.?

Cidara Therapeutics, Inc. all-time high TTM cash flow from investing activities is $57.61M

What is Cidara Therapeutics, Inc. TTM CFI year-on-year change?

Over the past year, CDTX TTM cash flow from investing activities has changed by +$406.00K (+124.16%)
On this page